Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock

Critical Care Medicine

Volumn 26, Issue 12, 1998, Pages 2005-2009

  Gando, Satoshi ^a   Nanzaki, Satoshi ^b   Sasaki, Shigeyuki ^a   Aoi, Kenichiro ^a   Kemmotsu, Osamu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SAPPORO CITY GENERAL HOSPITAL   (Japan)

Author keywords

Antithrombin III; D dimer; Disseminated intravascular coagulation; Fibrinopeptide A; Multiple organ dysfunction syndrome; Prothrombin fragment F1+2; Septic shock; Severe sepsis; Thrombin antithrombin III complex; Tissue factor

Indexed keywords

ANTITHROMBIN III; D DIMER; GABEXATE MESILATE; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FIBRIN FORMATION; HUMAN; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK;

ADULT; AGED; ANTITHROMBIN III; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; CASE-CONTROL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOPEPTIDE A; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; PROTHROMBIN; SEPSIS; SHOCK, SEPTIC; THROMBOPLASTIN;

EID: 0032446765     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199812000-00030     Document Type: Article

References (21)

1. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
2. Fourrier F, Chopin C, Goudemand J, et al: Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992; 101:816-823
3. Bone RC: Modulators of coagulation. A critical appraisal of their role in sepsis. Arch Intern Med 1992; 152:1381-1389
4. Thijs LG, de Boer JP, de Groot MCM, et al: Coagulation disorders in septic shock. Intensive Care Med 1993; 19: S8-S15
5. Levi M, ten Cate H, van der Poll T, et al: Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993; 270:975-979
6. Knaus WA, Draper EA, Wanger D, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
7. Murray JF, Matthay MA, Luce JM, et al: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-723
8. Gando S, Kameue T, Nanzaki S, et al: Participation of tissue factor and thrombin in posttrauma systemic inflammatory response syndrome. Crit Care Med 1997; 25:1820-1826
9. Ohno H, Kosaki G, Kambayashi J, et al: FOY:[Ethyl p-(6-guanidinohexanoyloxy) benzoate] methanesulfonate as a serine proteinase inhibitor. I. Inhibition of thrombin and factor Xa in vitro. Thromb Res 1980; 19:579-588
10. Ohono H, Kambayashi J, Chang SW, et al: FOY:[Ethyl p-(6-guanidinohexanoyloxy) benzoate] methanesulfonate as a serine proteinase inhibitor. II. In vivo effect on coagulofibrinolytic system in comparison with heparin or aprotinin. Thormb Res 1981; 24: 445-452
11. Salgado A, Bóveda JL, Monasterio J, et al: Inflammatory mediators and their influence on haemostasis. Haemostasis 1994; 24:132-138
12. van Deventer SJ, Buller HR, ten Cate JW, et al: Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic, and complement pathway. Blood 1990; 76:2520-2526
13. van der Poll T, Büller HR, ten Cate H, et al: Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990; 322:1622-1627
14. Brozna JP: Cellular regulation of tissue factor. Blood Coagl Fibrinol 1990; 1:415-426
15. Bone RC: The pathogenesis of sepsis. Ann Intern Med 1991; 115:457-469
16. Nakamura S, Kamikubo Y, Okajima K, et al: Plasma tissue factor: Its sensitive assay and characterization. Thromb Haemost 1994; 69:1250-1257
17. Asakura H, Kamikubo Y, Goto A, et al: Role of tissue factor in disseminated intravascular coagulation. Thromb Res 1995; 80:217-224
18. Fourrier F, Chopin C, Huart JJ, et al: Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 1993; 104:882-888
19. Fourier F, Jourdain M, Tournois A, et al: Coagulation inhibitor substitution during sepsis. Intensive Care Med 1995; 21:S264-S268
20. Lechner K, Kyrle PA: Antithrombin III concentrates - Are they clinically useful? Thromb Haemost 1995; 73: 340-348
21. Lorente JA, García-Frade LJ, Landín L, et al: Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 1993; 103:1536-1542